Death with Dipyridamole-Thallium Imaging
Authors: Harold Z. Friedman
Journal: Annals of Internal Medicine (1988)

Letters and Corrections15 December 1988Death with Dipyridamole-Thallium ImagingHarold Z. Friedman, MD, Scot F. Goldberg, MD, Andrew M. Hauser, MD, William W. O'Neill, MDHarold Z. Friedman, MD, Scot F. Goldberg, MD, Andrew M. Hauser, MD, William W. O'Neill, MDAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-109-12-990 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptDipyridamole-thallium 201 cardiac imaging is a sensitive and specific test for detecting coronary artery disease in patients unable to exercise effectively (1-3). Minor side effects from dipyridamole administration are common; however, morbidity is rare, and death has never been reported.A 77-year-old woman was hospitalized for increasingly severe, atypical chest pain. Her medical history showed hypertension and calf claudication. The results of recent echocardiographic study had shown concentric left ventricular hypertrophy, with normal contractility and aortic valve thickening. The peak aortic gradient was 20 mm Hg by Doppler study. Physical examination showed bilateral carotid bruits and fine bibasilar rales. Heart...References1. HommaCallahanAmeer SRB. Usefulness of oral dipyridamole suspension for stress thallium imaging without exercise in the detection of coronary artery disease. Am J Cardiol. 1986;57:503-8. CrossrefMedlineGoogle Scholar2. TailleferLettePhaneufLeveilleLemireEssiambre RJDJFR. Thallium-201 myocardial imaging during pharmacologic coronary vasodilatation: comparison of oral and intravenous administration of dipyridamole. J Am Coll Cardiol. 1986;8:76-83. CrossrefMedlineGoogle Scholar3. Borges-NetoMahmarianJainRobertsVerani SJARM. Quantitative thallium-201 single photon emission computed tomography after oral dipyridamole for assessing the presence, anatomic location and severity of coronary artery disease. J Am Coll Cardiol. 1988;11:962-9. CrossrefMedlineGoogle Scholar4. BaylissPearsonSutton JMG. Ventricular dysrhythmias following intravenous dipyridamole during "stress" myocardial imaging. Br J Radiol. 1983;56:686. CrossrefMedlineGoogle Scholar5. BlumenthalMcCauley MC. Cardiac arrest during dipyridamole imaging. Chest. 1988;93:103-4. CrossrefGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: Harold Z. Friedman, MD; Scot F. Goldberg, MD; Andrew M. Hauser, MD; William W. O'Neill, MDAffiliations: William Beaumont Hospital Royal Oak, MI 48072 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byRadiopharmaceuticalsSafety of and Tolerance to Adenosine Infusion for Myocardial Perfusion Single-Photon Emission Computed Tomography in a Japanese PopulationKontraindikationen, Nebenwirkungen und Abbruchkriterien streßechokardiographischer RoutinetechnikenComplications of pharmacologic stress echocardiography in coronary artery diseaseHemodynamic Responses and Adverse Effects Associated With Adenosine and Dipyridamole Pharmacologic Stress Testing: A Comparison in 2,000 PatientsSafety of dipyridamole testing in patients with cerebrovascular diseaseKontraindikationen und Nebenwirkungen streßechokardiographischer RoutinetechnikenIdentification of hemodynamically significant coronary artery stenoses by dipyridamole-magnetic resonance imaging and99mTc-methoxyisobutyl-isonitrile-SPECTSafety of intravenous high-dose dipyridamole echocardiographyPreoperative diagnosis of coronary artery disease in patients with valvular heart disease using technetium-99m isonitrile tomographic imaging together with high-dose dipyridamole and handgrip exerciseUses and limitations of high dose dipyridamole stress echocardiography for evaluation of coronary artery disease.Dipyridamole EchocardiographyUsefulness of technetium-99m-MIBI and thallium-201 in tomographic imaging combined with high-dose dipyridamole and handgrip exercise for detecting coronary artery diseaseTolerance and safety of pharmacologic coronary vasodilation with adenosine in association with thallium-201 scintigraphy in patients with suspected coronary artery diseaseMyocardial perfusion scintigraphy during maximal coronary artery vasodilation with adenosineRadiological contrast media and radiopharmaceuticalsVasodilator myocardial imaging.Acute myocardial infarction associated with intravenous dipyridamole for rubidium-82 pet imagingUpdate on intravenous dipyridamole cardiac imaging in the assessment of ischemic heart diseasePrognostic value of dipyridamole thallium scintigraphy for evaluation of ischemic heart diseaseMyocardial Infarction after Dipyridamole-Assisted Thallium-201 ImagingDipyridamole-Thallium Cardiac ImagingRobert N. Class, MD, Robert F. Carretta, MD, Phillip Matin, MD 15 December 1988Volume 109, Issue 12Page: 990-991KeywordsAortic valveExerciseHeartHeart diseasesHypertensionIschemiaLeft ventricular hypertrophyMorbidityStable coronary artery disease ePublished: 1 December 2008 Issue Published: 15 December 1988 PDF downloadLoading ...